Healio: Phase 2 trial: ADX-2191 may improve retinal function in patients with retinitis pigmentosa Phase 2 trial: ADX-2191 may improve retinal function in patients with retinitis pigmentosa Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach. Two new compounds ...
The American Journal of Managed Care: Depressive Disorder at Higher Risk of Development in Patients With Retinitis Pigmentosa Emotional and social support for patients with retinitis pigmentosa could reduce the incidence of depressive disorder in this demographic. RP is a rare disorder affecting between 1 in 3000 and 1 in ... Depressive Disorder at Higher Risk of Development in Patients With Retinitis Pigmentosa Ophthalmology Times: FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa Here’s what to know about the irreversible eye disease at the center of the new National Geographic documentary Blink. Retinitis pigmentosa is a rare visual disorder that affects a layer of tissue in ...
